Literature DB >> 29478029

Treatment of blood blister aneurysms of the internal carotid artery with flow diversion.

Maxim Mokin1, Angel Chinea1, Christopher T Primiani1, Zeguang Ren1, Peter Kan2, Visish M Srinivasan2, Ricardo Hanel3, Pedro Aguilar-Salinas3, Aquilla S Turk4, Raymond D Turner4, M Imran Chaudry4, Andrew J Ringer5, Babu G Welch6, Vitor Mendes Pereira7, Leonardo Renieri7, Mariangela Piano8, Lucas Elijovich9, Adam S Arthur9, Ahmed Cheema9, Demetrius Klee Lopes10, Ahmed Saied10, Blaise W Baxter11, Harris Hawk11, Ajit S Puri12, Ajay K Wakhloo12, Hussain Shallwani13, Elad I Levy13, Adnan H Siddiqui13, Guilherme Dabus14, Italo Linfante14.   

Abstract

BACKGROUND: Blood blister aneurysms (BBA) are a rare subset of intracranial aneurysms that represent a therapeutic challenge from both a surgical and endovascular perspective.
OBJECTIVE: To report multicenter experience with flow diversion exclusively for BBA, located at non-branching segments along the anteromedial wall of the supraclinoidal internal carotid artery (ICA).
METHODS: Consecutive cases of BBA located at non-branching segments along the anteromedial wall of the supraclinoidal ICA treated with flow diversion were included in the final analysis.
RESULTS: 49 patients with 51 BBA of the ICA treated with devices to achieve the flow diversion effect were identified. 43 patients with 45 BBA of the ICA were treated with the pipeline embolization device and were included in the final analysis. Angiographic follow-up data were available for 30 patients (32 aneurysms in total); 87.5% of aneurysms (28/32) showed complete obliteration, 9.4% (3/32) showed reduced filling, and 3.1% (1/32) persistent filling. There was no difference between the size of aneurysm (≤2 mm vs >2 mm) or the use of adjunct coiling and complete occlusion of the aneurysm on follow-up (P=0.354 and P=0.865, respectively). Clinical follow-up data were available for 38 of 43 patients. 68% of patients (26/38) had a good clinical outcome (modified Rankin scale score of 0-2) at 3 months. There were 7 (16%) immediate procedural and 2 (5%) delayed complications, with 1 case of fatal delayed re-rupture after the initial treatment.
CONCLUSIONS: Our data support the use of a flow diversion technique as a safe and effective therapeutic modality for BBA of the supraclinoid ICA. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  aneurysm; flow diverter; subarachnoid

Mesh:

Year:  2018        PMID: 29478029     DOI: 10.1136/neurintsurg-2017-013701

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  12 in total

1.  Thrombogenicity of the p48 and anti-thrombogenic p48 hydrophilic polymer coating low-profile flow diverters in an in vitro human thrombin generation model.

Authors:  Pervinder Bhogal; Tim Lenz-Habijan; Catrin Bannewitz; Ralf Hannes; Hermann Monstadt; Martin Brodde; Beate Kehrel; Hans Henkes
Journal:  Interv Neuroradiol       Date:  2020-05-04       Impact factor: 1.610

Review 2.  Stent-assisted Coiling vs. Flow Diverter for Treating Blood Blister-like Aneurysms : A Proportion Meta-analysis.

Authors:  Jeongjun Lee; Do Hyung Kim; Su Hwan Lee; Jung Hyeon Moon; Seung-Yeob Yang; Keun-Tae Cho; Bo Hae Kim
Journal:  Clin Neuroradiol       Date:  2022-04-11       Impact factor: 3.649

3.  Flow diverters for the posterior inferior cerebellar artery aneurysms: A systematic review and a single-arm meta-analysis.

Authors:  Xiang Liu; Kunyang Bao; Wenzhang Luo; Weifeng Wan; Tangming Peng; Changren Huang
Journal:  Interv Neuroradiol       Date:  2021-09-14       Impact factor: 1.764

4.  Application of the Willis Covered Stent in the Treatment of Blood Blister-Like Aneurysms: A Single-Center Experience.

Authors:  Wei Fang; Jia Yu; Yufeng Liu; Peng Sun; Zijian Yang; Zhenwei Zhao; Yue He; Jianping Deng; Tao Zhang
Journal:  Front Neurol       Date:  2022-05-18       Impact factor: 4.086

5.  The Cascade device - In vitro tests to assess coil protrusion into the parent vessel.

Authors:  P Bhogal; K Wong; Hld Makalanda
Journal:  Interv Neuroradiol       Date:  2020-05-11       Impact factor: 1.610

6.  Endovascular Treatment of Ruptured Intracranial Blister Aneurysms: A Systematic Review and Meta-analysis.

Authors:  A Scerrati; J Visani; M E Flacco; L Ricciardi; S Trungu; A Raco; F Dones; P De Bonis; C L Sturiale
Journal:  AJNR Am J Neuroradiol       Date:  2020-12-24       Impact factor: 3.825

7.  Endoluminal flow diverters in the treatment of sidewall and bifurcation aneurysm: A systematic review and meta-analysis of complications and angiographic outcomes.

Authors:  Mehdi Abbasi; Luis E Savasatano; Waleed Brinjikji; Kevin M Kallmes; Nick Mikoff; Natalie Reierson; Mohamed Abdelmegeed; John Pederson; Beth Warren; Jillienne C Touchette; Sarah Khan; Shelby Kamrowski; Averi Barrett; David F Kallmes; Ramanathan Kadirvel
Journal:  Interv Neuroradiol       Date:  2021-06-22       Impact factor: 1.764

8.  Overlapping Stents with Coil Sandwich for Ruptured Blood-blister Aneurysm in a Patient with Ipsilateral Persistent Primitive Trigeminal Artery: A Case Report and Review of Literature.

Authors:  Ryosuke Maeoka; Ichiro Nakagawa; Hiroyuki Ohnishi; Hiroyuki Nakase
Journal:  Asian J Neurosurg       Date:  2019-11-25

9.  Flow diverting devices in acute ruptured blood blister aneurysms: a three centric retrospective study.

Authors:  Francesca Incandela; Giuseppe Craparo; Sergio Abrignani; Agostino Tessitore; Antonio Pitrone; Ferdinando Caranci; Antonio Arrichiello; Aldo Paolucci
Journal:  Acta Biomed       Date:  2020-09-23

Review 10.  Outcomes after Flow Diverter Treatment in Subarachnoid Hemorrhage: A Meta-Analysis and Development of a Clinical Prediction Model (OUTFLOW).

Authors:  Michelle F M Ten Brinck; Viktoria E Shimanskaya; René Aquarius; Ronald H M A Bartels; Frederick J A Meijer; Petra C Koopmans; Guido de Jong; Ajay K Wakhloo; Joost de Vries; Hieronymus D Boogaarts
Journal:  Brain Sci       Date:  2022-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.